bivalent


Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

bivalent

[bī′vā·lənt]
(chemistry)
Possessing a valence of two.
References in periodicals archive ?
This bivalent recombinant LP2086 (rLP2086) vaccine candidate is being reviewed for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroup B in ten through 25 year olds, revealed the company.
Miniantibody: Bivalent (or bispecific) (scFv)2, so-called miniantibody, is produced by association of two scFv molecules through two modified dimerization domains.
Direct thrombin inhibitors are of 2 types: monovalent and bivalent. (6)
Only the bivalent vaccine is currently registered in Albania (11).
TABLE 1 HPV vaccine efficacy against HPV type-related CIN2+ in females ages ~15 to 26 years (3) Vaccine Placebo Efficacy Vaccine/ HPV type N CIN cases N CIN cases % CI * Bivalent HPV 16/18 7344 4 7312 56 93 80-98 HPV 16 6303 2 6165 46 96 83-100 HPV 18 6794 2 6746 15 87 40-99 Quadrivalent HPV 16/18 7738 2 7714 100 98 93-100 HPV 16 6647 2 6455 81 98 91-100 HPV 18 7382 0 7316 29 100 87-100 CI, confidence interval; CIN, cervical intraepithelial neoplasia; HPV, human papillomavirus.
During meiotic stages, 10 bivalents and a univalent x chromosome were observed.
In a report in the journal the Lancet, WHO experts said a study on the bivalent oral polio vaccine, known as bOPV, found it induced a "significantly higher immune response" than triple vaccines.
The paper, quoting the World Health Organisation, said research on the bivalent oral polio vaccine found that it induced a "significantly higher immune response" than triple vaccines.
It was observed that only a region comparable in length to the S11 bivalent is synapsed in each of the longest bivalents.
* For human papillomavirus (HPV), a bivalent vaccine (HPV2) has been licensed for use in females.
Al Wissam embraces the bivalent concept of day and night -- a breezy fragrance embodied in a white bottle representing a fresh start of a successful day positioned as a day fragrance.
-- The majority of a federal advisory panel agreed that the data on a recombinant bivalent human papillomavirus vaccine indicate that the vaccine is safe and effective in preventing cervical cancer and certain precancerous or dysplastic lesions caused by HPV types 16 and 18 in girls and women aged 10-25 years.